The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies.

Federico PirroGiacomo CaldarolaAndrea ChiricozziSara TamboneMarco Mariani Laura CalabreseDario Francesco D'UrsoClara De SimoneKetty Peris

Published in: The Journal of dermatological treatment (2020)

Uncertainty about whether biologics could increase the risk of SARS-CoV-2 infection led to drug withdrawal with subsequent worsening of psoriasis. Moreover, psychological status also had a direct influence on the clinical course of the disease.

Keyphrases

rheumatoid arthritis
disease activity
ankylosing spondylitis
respiratory syndrome coronavirus
adverse drug
sleep quality
systemic lupus erythematosus
atopic dermatitis
sars cov
drug induced
coronavirus disease
electronic health record